Telehealth ADHD Prescribing: What Psychiatric NPs Can Do

If you’re a psychiatrist or PMHNP wondering whether you can legally prescribe Adderall, Vyvanse, or other ADHD medications through telehealth — and where you can do it — you’re asking the right question. The answer is mostly yes, but it’s complicated by federal waivers, state-specific scope limitations, and evolving DEA rules that could change in 2026.

Here’s what you need to know about ADHD prescribing via telehealth: the regulations, the economics, and why platforms like Klarity Health make it easier to serve this massive patient population without the marketing gamble.

Federal Telehealth Rules: Where We Stand in 2026

The Short Answer: As of February 2026, psychiatrists can still prescribe Schedule II stimulants (Adderall, Ritalin, Vyvanse) via telehealth to new patients without an initial in-person visit — but this flexibility is temporary.

Here’s the timeline: Pre-COVID, the Ryan Haight Act required an in-person medical evaluation before any controlled substance could be prescribed via telemedicine. That rule was waived during the Public Health Emergency, allowing providers to start stimulant prescriptions entirely online. The DEA has extended these flexibilities multiple times — most recently through December 31, 2025 — marking the third temporary extension of pandemic-era telehealth rules.

What happens in 2026? Unless Congress passes permanent legislation or the DEA finalizes new rules, we could revert to the Ryan Haight Act’s in-person requirement. The DEA has proposed a ‘special registration’ pathway for telemedicine prescribing of controlled substances, but nothing concrete has been implemented yet.

Bottom line for psychiatrists: You can prescribe ADHD meds via telehealth right now under the federal extension. But have a contingency plan — partnering with local clinics for occasional in-person exams, or being ready to pivot if regulations tighten. The regulatory uncertainty is real, but patient demand isn’t going anywhere.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-Specific Telehealth Laws: Where You Can Practice

Federal law sets the floor, but states add their own rules. Some states explicitly welcome psychiatric telehealth prescribing; others add restrictions that complicate ADHD care.

States That Explicitly Allow Telehealth ADHD Prescribing

Florida stands out: Florida law explicitly permits prescribing Schedule II controlled substances via telehealth when treating psychiatric disorders. The statute carves out mental health conditions (including ADHD) from its general telehealth controlled-substance ban. If you’re treating ADHD — not chronic pain — you’re in the clear for video-based prescribing in Florida.

Texas doesn’t prohibit telehealth prescribing of stimulants for mental health, but it does require synchronous audio-video (no phone-only prescribing for controlled substances). Texas banned telemedicine for chronic pain management with controlled substances, but ADHD treatment doesn’t fall under that restriction. You need video, proper documentation, and a Texas medical license — but it’s doable.

California, New York, Illinois, and Pennsylvania generally defer to federal law without adding state-specific telehealth barriers for psychiatric prescribing. These states require e-prescribing (mandatory in most states by 2026) and Prescription Drug Monitoring Program (PDMP) checks, but don’t block telehealth stimulant prescriptions.

What About PDMP Requirements?

Most states mandate PDMP checks before prescribing Schedule II drugs. New York requires checking the registry for every controlled substance prescription. Florida requires PDMP consultation before prescribing Schedule II-IV. Texas technically only mandates checks for opioids and benzos by law, but best practice is to check for stimulants too.

These are workflow considerations, not barriers. Most telehealth platforms integrate PDMP access directly into their prescribing systems.

Psychiatrists vs PMHNPs: Who Can Prescribe What, Where

This is where scope of practice gets messy — and where being a psychiatrist (MD/DO) matters most.

Psychiatrists: Full Authority Everywhere

If you’re a psychiatrist, you have unrestricted prescriptive authority in all 50 states (assuming proper licensing and DEA registration). You can prescribe any Schedule II-V medication without supervision, collaborative agreements, or quantity limits. Federal and state controlled-substance laws apply, but your scope of practice is never the bottleneck.

For telehealth ADHD prescribing, this means:

• You can evaluate and start a patient on stimulants entirely via video (under current federal rules)
• You can manage ongoing medication for established patients
• You don’t need a physician supervisor, protocol, or collaborative agreement
• You can practice independently on platforms like Klarity across multiple states (with proper licensure)

PMHNPs: It Depends on Your State

Nurse practitioners face a patchwork of state regulations that directly impact ADHD prescribing. Here’s the breakdown:

Full Practice Authority States (After Experience):

• New York: PMHNPs need 3,600 hours of supervised practice (~2 years), then can prescribe independently including Schedule II stimulants. No quantity limits, no physician co-signatures.
• California: Transitioning to independence. Experienced NPs (≥3 years/4,600 hours) can apply for independent ‘104 NP’ status. Must complete a controlled-substance pharmacology course to prescribe Schedule IIs. Until independent, requires physician supervision.
• Illinois: NPs can obtain Full Practice Authority after 4,000 hours + 250 hours additional training. Once granted, can prescribe ADHD meds independently (no physician consult required for stimulants, unlike opioids).

Restricted Practice States:

• Texas: This is the big one. Texas law prohibits NPs from prescribing Schedule II controlled substances outside hospital/hospice settings. That means a Texas PMHNP cannot write Adderall prescriptions for outpatient ADHD patients — period. Only physicians can. NPs need supervising physicians for all practice, and even then, stimulant prescribing is off-limits in routine care.
• Florida: NPs require a collaborative protocol with a supervising physician (must be a psychiatrist for psychiatric NPs). Florida limits NPs to 7-day supplies of Schedule IIs — except for ‘psychiatric nurses’ treating mental health conditions, who are exempt from this limit. So a PMHNP working under a psychiatrist’s protocol can prescribe 30-day stimulant supplies, but still needs that oversight.
• Pennsylvania: NPs need collaborative agreements and face strict limits: 72-hour initial supply for new Schedule II prescriptions (must notify supervising physician), then 30-day supplies for ongoing therapy. The physician must re-evaluate before continuation beyond 30 days.

The Practical Difference

If you’re a psychiatrist joining a telehealth platform, you can serve patients in any state where you’re licensed — no collaborative agreements needed, no quantity limits to navigate.

If you’re a PMHNP:

• In New York (post-3,600 hours), California (post-independence), or Illinois (with FPA), you’re essentially equivalent to an MD for ADHD prescribing
• In Texas, you’ll need an MD partner to prescribe stimulants — your role will be therapy, non-stimulant management, or follow-ups with the psychiatrist writing controlled scripts
• In Florida and Pennsylvania, you can prescribe with physician oversight, but expect more administrative coordination

For platforms like Klarity: This scope variability is why psychiatrists are in especially high demand for states like Texas and Florida. If you’re an MD, you’re the linchpin that allows NP colleagues to extend care. If you’re an NP in a restricted state, you’ll likely work alongside psychiatrists rather than solo.

The Economics: What ADHD Telehealth Actually Pays

Let’s talk money, because ‘Will I get paid appropriately?’ is often the real question.

Insurance Reimbursement Rates

Telehealth payment parity is now nearly universal for mental health services. As of 2026, 48 states have telehealth parity laws or policies ensuring video visits are reimbursed at the same rate as in-person.

Medicare rates (2024-2025 fee schedules):

• 99213 (15-minute med check): ~$89-95
• 99214 (25-minute visit): ~$125-136
• 90792 (initial psychiatric eval): ~$188-202

Commercial insurance typically pays equal to or higher than Medicare — often 10-30% more depending on the plan. Medicaid pays substantially less (roughly $40-65 for a med check in many states), but Medicaid telehealth coverage has expanded significantly post-pandemic.

Key point: Psychiatrists are reimbursed at the highest levels for psychiatric services compared to other provider types. Your MD/DO credential commands top rates, whether in-person or virtual.

The Platform Economics Model

Here’s where telehealth platforms differ from building your own practice.

Traditional DIY marketing reality:

• SEO takes 6-12 months of consistent investment before generating meaningful patient flow
• Google Ads for mental health keywords cost $15-40+ per click; realistic cost per booked patient through PPC is $200-400+
• Psychology Today, Zocdoc, and other directories charge monthly fees ($30-100+) and you compete with hundreds of providers on the same page
• Total monthly marketing spend: $3,000-5,000+ with uncertain ROI and months before results

When you factor in agency fees, ad testing, staff time to qualify leads, no-show rates from cold traffic, and failed campaigns, acquiring a qualified psychiatric patient costs $200-500+ all-in — and that’s if you have the expertise and patience.

Klarity’s model: Pay-per-appointment, similar to Zocdoc but built specifically for psychiatry. You pay a standard listing fee per new patient lead. The value proposition:

• No upfront marketing spend or monthly subscription fees
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate EMR or platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only pay when you see patients

That’s guaranteed ROI vs gambling on marketing channels. Instead of spending $5,000/month hoping to attract patients, you pay only when a qualified ADHD patient books with you. For most providers — especially those starting out or scaling — removing patient acquisition risk entirely is worth the per-appointment fee.

Revenue Potential

If you’re doing ADHD medication management:

• Four 15-minute med checks per hour = ~$360/hour gross (Medicare rates)
• Commercial insurance typically pays higher
• Telehealth overhead is minimal (no office lease, reduced staff)
• High patient demand = easy schedule fills

The constraint isn’t patient volume — it’s how many hours you want to work. ADHD telehealth lets you design a practice around your life instead of commuting to an office and hoping your marketing works.

ADHD Medication Shortages: A Current Reality

Let’s acknowledge the elephant in the room: ADHD medication shortages have been ongoing since late 2022. Prescriptions for ADHD treatments surged during the pandemic — adult ADHD prescriptions jumped significantly in 2020-2022 as telehealth made diagnosis more accessible. That demand spike, combined with DEA manufacturing quotas and supply chain issues, created persistent shortages of Adderall, Vyvanse, and other stimulants.

What this means for providers:

• You’ll field frustrated patient calls when pharmacies can’t fill prescriptions
• Have a plan for alternatives: non-stimulants (atomoxetine, viloxazine), different stimulant formulations, or helping patients find pharmacies with stock
• Documentation becomes critical — if you’re switching medications due to supply issues, note it clearly
• Some patients may need more frequent check-ins during transitions

The DEA has increased manufacturing limits in response, but shortages persist as of early 2026. This is a pain point, but also an opportunity to demonstrate real clinical value — patients need providers who can navigate this complexity, not just write scripts.

Clinical Workflows: How to Do ADHD Telehealth Right

ADHD medication management via telehealth isn’t just legally permissible — it’s clinically sound when done properly. Here’s the standard of care:

Initial Evaluation (45-60 minutes)

• Comprehensive psychiatric interview via video
• DSM-5 diagnostic criteria confirmation
• Standardized rating scales (ADHD RS-IV for kids, ASRS for adults) sent electronically
• Collateral information when appropriate (teacher forms for children, partner input for adults)
• Mental status exam via video observation
• Rule out medical causes (ask about recent vitals, cardiac history)
• Document baseline: blood pressure, heart rate (patient self-report or PCP data)

Code: 90792 (psychiatric diagnostic evaluation with medical services)

Medication Initiation

• E-prescribe via DEA-compliant platform (required in most states by 2026)
• Check PDMP before prescribing
• Informed consent covering stimulant risks, side effects, monitoring plan
• Start conservative (especially with adults new to treatment)
• Schedule follow-up in 2-4 weeks to assess response

Ongoing Management (15-25 minutes monthly)

• Symptom monitoring (work/school functioning, side effects, sleep, appetite)
• Vital signs check (patient self-monitoring or PCP coordination)
• Assess adherence and any misuse concerns
• PDMP checks (at least every 3 months, many check monthly)
• Dose adjustments as needed
• Refill prescription (30-day supply standard for Schedule II)

Codes: 99213 (15-min) or 99214 (25-min) for established patient med management

Compliance Safeguards

Given increased scrutiny after some telehealth companies over-prescribed stimulants with minimal oversight, legitimate providers emphasize:

• Thorough documentation aligned with DSM-5 criteria
• Regular follow-ups (not just prescription renewals)
• Patient agreements outlining expectations and monitoring
• Urine drug screening if clinical concerns arise
• Coordination with PCPs, especially for patients with comorbidities
• Clear policies on early refills (usually no)

This level of diligence demonstrates that telehealth ADHD prescribing meets the same standard as in-person care — which is exactly what state laws like Florida’s require.

State-by-State ADHD Prescribing Summary

Here’s a quick reference for the six priority states:

Why Provider Shortages Make This Opportunity Urgent

Let’s look at the workforce data:

• Texas: ~1 psychiatrist per 9,000 residents (rank 43rd nationally) — severe shortage
• Florida: ~1 per 8,577 (rank 42nd) — significant shortage
• Pennsylvania: ~1 per 4,586 (rank 10th) — moderate, but rural gaps
• Illinois: ~1 per 5,849 (rank 18th) — adequate in Chicago, shortages elsewhere
• California: ~1 per 5,636 (rank 11th) — large numbers but also huge underserved populations
• New York: ~1 per 2,900 (rank 4th) — best ratio, but still rural shortages upstate

What this means: In Texas and Florida, ADHD patients are waiting months for appointments. In rural Pennsylvania and downstate Illinois, they may drive hours to see a psychiatrist. In California and New York, urban competition is high but so is demand — especially for adult ADHD, which surged during the pandemic as remote work made symptoms more visible and telehealth made help more accessible.

Telehealth is the solution to geographic maldistribution. A psychiatrist licensed in Texas can serve patients from Amarillo to Brownsville without leaving their home office. An experienced PMHNP in New York can fill gaps upstate while living in Brooklyn.

The patient demand is there. The reimbursement infrastructure supports it. The regulatory environment (mostly) permits it. The constraint is provider supply.

Why Klarity Makes More Sense Than Going Solo

If you’re a psychiatrist or PMHNP considering ADHD telehealth, you have options: join a platform, build your own practice, or stay in traditional employment.

The DIY Practice Reality

Building your own telehealth practice means:

• 6-12 months before SEO generates consistent leads
• $3,000-5,000/month in marketing spend (Google Ads, directory listings, website, SEO services)
• Learning (or hiring) expertise in: landing page conversion, ad campaign management, patient lead qualification, insurance credentialing, billing operations
• Managing tech stack: telehealth platform, EHR, e-prescribing, PDMP integration, patient portal
• No patient flow guarantee — you’re betting thousands that your marketing will work

And that’s before you see a single patient.

For established providers with capital and patience, this can work. But for most providers — especially those starting telehealth or scaling up — the risk-to-reward doesn’t pencil.

The Platform Model

Platforms like Klarity remove patient acquisition risk entirely:

• Pre-qualified patient flow from day one
• No upfront marketing costs — you pay per appointment, not per experiment
• Built-in infrastructure — EHR, telehealth tech, e-prescribing, credentialing support
• Insurance and cash-pay mix — diversified revenue without contracting hassle
• You control your schedule — work 10 hours/week or 40, evenings or mornings

The per-appointment fee is your patient acquisition cost — but it’s guaranteed. You only pay when a qualified patient books and shows up. Compare that to spending $5,000/month on Google Ads hoping to convert strangers into patients, many of whom no-show or aren’t a fit.

For ADHD specifically: Patient demand is high, visits are relatively brief (med checks), and reimbursement is solid. The economics work even with a platform fee because your volume can scale quickly without the overhead of office rent, front-desk staff, or failed marketing campaigns.

What to Do Next

If you’re a psychiatrist or PMHNP interested in ADHD telehealth:

1. Get licensed in high-demand states. Texas, Florida, and Pennsylvania have severe shortages and favorable telehealth laws (despite NP restrictions in TX/FL, they need MDs). California and Illinois are large markets with growing NP autonomy. New York has the best infrastructure and NP-friendly laws.

2. Understand your state’s scope. If you’re an NP in Texas, you’ll need to partner with a psychiatrist platform or practice. If you’re in New York with 3,600+ hours, you’re autonomous. If you’re a psychiatrist anywhere, you’re in demand.

3. Get credentialed properly. DEA registration, state controlled-substance licenses, PDMP access, e-prescribing setup. Most platforms handle credentialing support, but know what’s required.

4. Choose your model. DIY if you have capital, time, and marketing expertise. Platform if you want patient flow now without the gamble.

5. Focus on quality. The telehealth ADHD space has been scrutinized after some companies cut corners. Differentiate yourself with thorough evaluations, appropriate monitoring, and genuine care. That’s what patients need — and what regulators expect.

The bottom line: Yes, psychiatrists can prescribe ADHD medications via telehealth in 2026 — and PMHNPs can too in many states, though scope limitations vary. The regulatory landscape is in flux, but current federal extensions allow online stimulant prescribing through at least the end of 2025. Patient demand is enormous, reimbursement is solid, and platforms like Klarity offer a lower-risk path to building a sustainable telehealth practice than DIY marketing.

If you’re ready to serve the massive unmet need for ADHD care without gambling thousands on marketing that might not work, explore joining Klarity’s provider network and start seeing patients who actually need your expertise.

FAQ: ADHD Telehealth Prescribing for Providers

Can I prescribe Adderall via telehealth in 2026?
Yes, if you’re a licensed psychiatrist (MD/DO) or PMHNP with prescriptive authority in your state. Current federal rules (extended through December 2025) allow prescribing Schedule II stimulants via telehealth without an initial in-person visit. Check your state’s scope of practice and telehealth laws for any additional requirements.

Do I need to see ADHD patients in-person before prescribing stimulants?
Not currently, under the federal telehealth extension. However, this could change if the Ryan Haight Act’s in-person requirement resumes in 2026. Have a contingency plan (partner clinic for in-person exams if needed), but for now, video evaluations are sufficient under federal law.

Can PMHNPs prescribe ADHD medications independently?
It depends on your state. In New York (after 3,600 hours), California (with 104 NP status), and Illinois (with Full Practice Authority), yes. In Texas, no — NPs cannot prescribe Schedule II stimulants for outpatient ADHD. In Florida and Pennsylvania, NPs can prescribe with physician oversight and some quantity limitations.

What states are best for telehealth ADHD prescribing?
Florida explicitly allows telehealth prescribing of Schedule IIs for psychiatric disorders. Texas, California, Illinois, Pennsylvania, and New York permit it under federal rules without extra state barriers. Texas and Florida have the worst psychiatrist shortages (highest demand), while New York has the best infrastructure and NP-friendly scope laws.

How much can I earn doing ADHD medication management via telehealth?
Medicare reimburses ~$89-95 for a 15-minute med check (99213) and ~$125-136 for a 25-minute visit (99214). Commercial insurance typically pays equal or higher. At four 15-minute appointments per hour, that’s ~$360/hour gross at Medicare rates. Actual income depends on payer mix, overhead (minimal for telehealth), and schedule density.

What’s the biggest challenge in ADHD telehealth right now?
Regulatory uncertainty (will federal telehealth flexibility continue?) and medication shortages (Adderall, Vyvanse supply issues since 2022). Both require flexibility — have backup medication options and contingency plans for potential in-person requirements.

Do telehealth platforms really deliver qualified patients, or is it marketing hype?
Legitimate platforms like Klarity pre-qualify patients based on your specialty, state license, and availability. You’re not paying for random clicks — you pay per booked appointment. The alternative (DIY marketing) costs $200-500+ per acquired patient with no guarantee. Platforms remove that risk: you only pay when patients show up.

How do I stay compliant prescribing controlled substances via telehealth?
Check your state PDMP before prescribing (mandatory in most states), use DEA-compliant e-prescribing, document thorough evaluations aligned with DSM-5, maintain regular follow-ups (monthly for stimulants), verify patient identity and location each visit, and keep informed consent documented. Treat it like in-person care — because legally, the standard is the same.

Sources & Citations

The following sources were used to compile this guide. All links were accessed and verified in February 2026:

Federal & State Regulations:

• Florida Statutes §456.47 (Telehealth – controlled substances exceptions) – flsenate.gov
• Florida Statutes §464.012 (APRN prescribing authority and limits) – leg.state.fl.us
• Texas Senate Bill 2527 Analysis (88th Legislature, 2023) – capitol.texas.gov
• Center for Connected Health Policy (CCHP) – Texas State Telehealth Laws (updated Jan 19, 2026) – cchpca.org/texas
• Pennsylvania Code Title 49 §21.284 (CRNP prescribing parameters)
• Illinois Nurse Practice Act – 225 ILCS 65 (APRN Full Practice Authority)

Federal Policy Updates:

• Axios News – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024) – axios.com
• Axios News – ‘Telehealth prescribing mess could reach Congress’ (Sept 18, 2024) – axios.com

Provider Workforce & Market Data:

• Healing Psychiatry Florida – ‘Psychiatrist Shortage by State – 2026 Report’ (Jan 15, 2026) – healingpsychiatryflorida.com
• Texas Tribune – ‘Texas’ shortage of mental health care professionals is getting worse’ (Feb 21, 2023)

Scope of Practice & Prescriptive Authority:

• RxAgent – ‘NP Prescriptive Authority by State (2026 Guide)’ (Updated Dec 28, 2025) – rxagent.co

ADHD Treatment Trends & Medication Shortages:

• Associated Press – ‘More adults sought help for ADHD during pandemic’ (Jan 10, 2024) – apnews.com
• Axios Vitals Newsletter – ‘DEA ramps up production of ADHD meds’ (Sept 5, 2024)

Reimbursement Data:

• Therathink – ‘Insurance Reimbursement Rates for Psychiatrists [2026]’ (Updated 2026) – therathink.com
• BehaveHealth – ‘Mental Health Reimbursement Trends – Telehealth Parity 2026’ (2024) – behavehealth.com
• Kiplinger – ‘Medicare Telehealth Expanded in 2025’ – kiplinger.com

All regulatory and scope-of-practice statements have been cross-checked against current official sources (state statutes or regulatory bodies where possible). Data from 2023-2026 was used for the latest rules. State-specific claims were verified with state law or state board references. The content reflects the regulatory environment as of late February 2026, with the understanding that telehealth prescribing rules are subject to change pending federal action later in 2026.

Source:

• https://www.axios.com/2024/09/18/telehealth-services-controlled-substances-congress#:~:text=Why%20it%20matters%3A%20Pandemic,end%20of%20this%20year%20after
• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,the%20third%20temporary%20extension%20of
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=,is%20prescribed%20for%20the%20following
• https://www.flsenate.gov/Laws/Statutes/2023/456.47#:~:text=1,disorder
• https://rxagent.co/blog/np-prescribing-authority#:~:text=OK%20%20,day%20%28ongoing%29%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=TN%20%20,NP%3A%20Independent%20%5B3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=match%20at%20L210%20NY%20,terminal%20illness%2C%20MD%20initiation
• https://rxagent.co/blog/np-prescribing-authority#:~:text=ID%20%20,3
• https://rxagent.co/blog/np-prescribing-authority#:~:text=FL%20%20,NP%3A%20Independent%20%5B3
• https://www.leg.state.fl.us/STATUTeS/index.cfm?Appmode=DisplayStatute&Search_String=&URL=0400-0499%2F0464%2FSections%2F0464.012.html#:~:text=also%20limit%20the%20prescribing%20of,shall%20adopt%20by%20rule%20the